title: Hair loss, depigmentation of hair, ichthyosis, and blepharoconjunctivitis produced by dixyrazine.
abstract: Four patients developed hair loss, depigmentation of hair, ichthyosis, and blepharoconjunctivitis during treatment with large doses of dixyrazine (Esucos, UCB, Belgium). The hair, skin, and eyes returned to normal within 2 months of withdrawal of dixyrazine, without any other treatment.
mesh_terms: D000328:Adult; D000505:Alopecia / Q000139:chemically induced*; D001762:Blepharitis / Q000139:chemically induced*; D003231:Conjunctivitis / Q000139:chemically induced*; D005141:Eyelid Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007057:Ichthyosis / Q000139:chemically induced*; D008297:Male; D010640:Phenothiazines / Q000009:adverse effects*; D010859:Pigmentation Disorders / Q000139:chemically induced*
chemical_list: D010640:Phenothiazines; C012950:dixyrazine